MS
BMY icon

Maven Securities’s Bristol-Myers Squibb BMY Stock Holding History

Maven Securities’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-16,688
Closed -$944K – 801
2024
Q4 		$944K Sell
16,688
-51,168
-75% -$2.86M 0.02% 428
2024
Q3 		$46.8K Hold
67,856
– – ﹤0.01% 853
2024
Q2 		$46.8K Hold
67,856
– – ﹤0.01% 896
2024
Q1 		$46.8K Buy
+67,856
New +$3.46M ﹤0.01% 333
2022
Q4 		– Sell
-25,756
Closed -$1.94M – 863
2022
Q3 		$1.83M Buy
+25,756
New +$1.87M 0.03% 339
2022
Q1 		– Sell
-4,917
Closed -$330K – 980
2021
Q4 		$307K Buy
4,917
+2,773
+129% +$163K 0.01% 687
2021
Q3 		$127K Sell
2,144
-5,856
-73% -$386K ﹤0.01% 982
2021
Q2 		$535K Buy
+8,000
New +$522K 0.02% 622

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Maven Securities's BMY Position: Q1 2025 in Review

Maven Securities sold out of Bristol-Myers Squibb (BMY) in Q1 2025, closing a stake of 16,688 shares — an estimated $944K sold.

Maven Securities first reported a position in BMY in Q2 2021 and held it in 8 quarters. The position peaked at $1.83M in Q3 2022. 2,486 funds tracked by Wall St. Rank hold BMY as of Q1 2025.

  • Maven Securities reported no remaining Bristol-Myers Squibb position as of Q1 2025 after selling out during the quarter.
  • Maven Securities sold 16,688 Bristol-Myers Squibb shares in Q1 2025, an estimated $944K.
  • Maven Securities first reported a position in Bristol-Myers Squibb in Q2 2021 and held it in 8 quarters.
  • Maven Securities's Bristol-Myers Squibb position peaked at $1.83M in Q3 2022.
  • 2,486 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2025.

Based on Maven Securities's 13F filing for Q1 2025, filed 14 May 2025.